Finnrick - Ensuring a Safer and More Transparent Supply Chain
Yimei

Yimei

Ipamorelin

Finnrick tested 6 samples of Ipamorelin (GHS agonist) from Yimei between 23 Oct 2025 and 6 Mar 2026. Test scores average over 6, no score below 5, and at least 6 tests warrant a confident Finnrick Rating of B (Good).

Finnrick Rating™
Yimei
Ipamorelin
Tested 6 Samples
Last test 6 Mar 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Ipamorelin tests from Yimei

Samples are tested in commercial labs

Tests Count

6

Scores

AVG7.4MIN5.7MAX9.7

Last

6 Mar 2026

First

23 Oct 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityEndotoxinsBatch IDContainerTested AtSent By
6 Mar 2026View5.75mg4.28mg-14.4%99.90%n/a(no batch ID)No Label / Silver Crimp / Clear Pink CapLab EPublic
2 Mar 2026View7.95mg4.73mg-5.4%99.90%
below LOQ
(no batch ID)No Label / Silver Crimp / Green CapLab EPublic
26 Feb 2026View7.15mg4.69mg-6.2%99.70%n/a(no batch ID)(no data)Lab EPublic
20 Feb 2026View9.710mg10.6mg+6.0%99.90%n/aIp10No Label / Silver Crimp / Red CapLab EPublic
4 Feb 2026View6.35mg4.5mg-10.0%99.80%n/a(no batch ID)No Label / Silver Crimp / Green CapLab GPublic
23 Oct 2025View8.010mg9.7mg-3.0%99.95%n/a(no batch ID)No Label / Silver Crimp / Red Cap Lab EPublic